Dr. Erik Waara, Ph.D.
Head of Pre-Clinical Development
Dr. Erik Rollman Waara received his Ph. D. from Karolinska Institutet, Stockholm, Sweden in 2004 after performing preclinical HIV vaccine research, under the supervision of Prof. Britta Wahren. In 2005, he joined Prof. Stephen J Kent’s laboratory at the University of Melbourne, Australia, where he worked on virus induced cellular immunity, studies supported by the Swedish Research Council (Vetenskapsrådet). After returning to Stockholm, Sweden in 2008, he joined BioArctic AB where he conducted hands-on pre-clinical research and development, generating antibody-based biotherapeutics in the fields of Alzheimer’s and Parkinson’s diseases. In September 2017, he joined Sigrid Therapeutics AB as Head of Pre-Clinical Development.